Geranyl phenyl ethers from Illicium micranthum and their anti-HBV activity
Yu Liu,Yun-Xia You,Li Rao,Qian He,Yu Su,Yue Fan,Yi-Zhou Li,You-Kai Xu,Chuan-Rui Zhang,Yu LIU,Yun-Xia YOU,Li RAO,Qian HE,Yu SU,Yue FAN,Yi-Zhou LI,You-Kai XU,Chuan-Rui ZHANG
DOI: https://doi.org/10.1016/s1875-5364(21)60112-7
IF: 3.887
2022-02-01
Chinese Journal of Natural Medicines
Abstract:Fourteen new geranyl phenyl ethers (1–14) along with three known compounds (15–17) were isolated from Illicium micranthum, and their structures were elucidated by comprehensive spectroscopic methods. Illimicranins A–H (1–8) were characterized as geranyl vanillin ethers, while 9 and 10 were dimethyl acetal derivatives. Illimicranins I and J (11 and 12) were rare geranyl isoeugenol ethers. Illimicranins K and L (13 and 14) represented the first example of geranyl guaiacylacetone ether and geranyl zingerone ether, respectively. Compounds 1, 2 and 15 exhibited anti-HBV (hepatitis B virus) activity against HBsAg (hepatitis B surface antigen) and HBeAg (hepatitis B e antigen) secretion, and HBV DNA replication.
pharmacology & pharmacy,integrative & complementary medicine